Successful Thrombolysis of a Thrombosed Mechanical Aortic Valve Prosthesis Using a Slow Intravenous Tenecteplase Infusion
Keywords:thrombolysis, aortic valve, prosthetic valve thrombosis
Prosthetic valve thrombosis is defined as any obstruction of prosthesis by non-infective thrombotic material. It has an estimated incidence of 0.03%-4.3% per year and is reported to occur in 0.5%-8% of the left-sided prosthetic valves and in up to 20% of tricuspid prosthesis. We describe a successful treatment of a young man presented with a thrombosed prosthetic aortic valve using a slow intravenous infusion of Tenecteplase without any bolus dose in a newly described dose regimen for aortic valve position and with a complete resolution of the thrombus and regaining the full mobility of both valve leaflets within 48 hours.
Caceres-Loriga FM, Perez-Lopez H, Santos-Gracia J, et al. Prosthetic heart valve thrombosis: pathogenesis, diagnosis and management. Int J Cardiol 2006;110:1-6.
Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 129 (23):e521-643.
Lengyel M, Horstkotte D, VoÂ¨ller H, e al. Working Group Infection, Thrombosis, Embolism and Bleeding of the Society for Heart Valve Disease. Recommendations for the management of prosthetic valve thrombosis. J Heart Valve Dis 2005;14:567-575.
Roudaut R, Lafitte S, Roudaut MF, et al. Management of prosthetic heart valve obstruction: fibrinolysis versus surgery. Early results and long-term follow-up in a single-centre study of 263 cases. Arch Cardiovasc Dis 2009;102:269-277.
Charokopos N, Antonitsis P, Artemiou P, et al. Acute mechanical prosthetic valve thrombosis after initiating oral anticoagulation therapy. Is bridging anticoagulation with heparin required? Interact Cardiovasc Thorac Surg 2009;9:685-687.
Al-Sarraf N, Al-Shammari F, Al-Fadhli J, et al. Successful thrombolysis of a thrombosed prosthetic mitral valve using a synthetic tissue plasminogen activator: a case report. J Med Case Reports 2010, 4:241-244.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under aÂ Creative Commons Attribution LicenseÂ that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeÂ The Effect of Open AccessÂ and Benefits of Publishing Open Access).